Aclaris Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ACRS) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -22 M8.94 M13.06 M9.99 M10.93 M13.13 M 47.11 M Cash from investing activities 2.79 M50.81 M19.12 M5.05 M13.83 M10.37 M 48.37 M Cash from financing activities -22 K74.49 M275 K9 0003.04 M2.53 M 5.86 M Free cash flow -22 M8.94 M12.18 M9.97 M10.91 M13.11 M 46.17 M

Notizie

Stifel alza il target su Aclaris Therapeutics a $3 per la pipeline

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Gli EPS di Aclaris Therapeutics Inc hanno mancato le aspettative per 0,01$, il fatturato appena sotto le previsioni

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris avvia trial di fase 1b di ATI-052 in pazienti asmatici

Aclaris starts phase 1b trial of ATI-052 in asthma patients

Craig-Hallum avvia copertura su Aclaris Therapeutics con rating Buy

Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating

Aclaris: H.C. Wainwright riafferma rating Buy dopo risultati preclinici positivi